GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30203% above fair value
$233.08−10.17 (-4.18%)
Close on Nov 18, 2026Market cap $13.80BP/E –Yield –
Glaukos shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Glaukos's shares outstanding was 61M at Sep 30, 2026. For fiscal 2025 it was 57M, up 8.4% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is 57M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57M | +8.4% |
| FY2024 | Dec 31, 2024 | 53M | +8.9% |
| FY2023 | Dec 31, 2023 | 48M | +2.1% |
| FY2022 | Dec 31, 2022 | 47M | +2.2% |
| FY2021 | Dec 31, 2021 | 46M | +4.3% |
| FY2020 | Dec 31, 2020 | 44M | +8.1% |
| FY2019 | Dec 31, 2019 | 41M | +16.5% |
| FY2018 | Dec 31, 2018 | 35M | +2.7% |
| FY2017 | Dec 31, 2017 | 34M | -5.7% |
| FY2016 | Dec 31, 2016 | 36M | +108.6% |
| FY2015 | Dec 31, 2015 | 17M | +661.7% |
| FY2014 | Dec 31, 2014 | 2M | +12.7% |
| FY2013 | Dec 31, 2013 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 61M | +6.6% |
| Q2 FY2026 | Jun 30, 2026 | 59M | +2.8% |
| Q1 FY2026 | Mar 31, 2026 | 58M | +2.4% |
| Q4 FY2025 | Dec 31, 2025 | 58M | +3.4% |
| Q3 FY2025 | Sep 30, 2025 | 57M | +4.3% |
| Q2 FY2025 | Jun 30, 2025 | 57M | +12.8% |
| Q1 FY2025 | Mar 31, 2025 | 57M | +14.2% |
| Q4 FY2024 | Dec 31, 2024 | 56M | +13.8% |
| Q3 FY2024 | Sep 30, 2024 | 55M | +13.1% |
| Q2 FY2024 | Jun 30, 2024 | 51M | +5.0% |
| Q1 FY2024 | Mar 31, 2024 | 50M | +3.5% |
| Q4 FY2023 | Dec 31, 2023 | 49M | +2.4% |
| Q3 FY2023 | Sep 30, 2023 | 49M | +2.2% |
| Q2 FY2023 | Jun 30, 2023 | 48M | +2.0% |
| Q1 FY2023 | Mar 31, 2023 | 48M | -3.3% |
| Q4 FY2022 | Dec 31, 2022 | 48M | +1.7% |
| Q3 FY2022 | Sep 30, 2022 | 48M | -3.5% |
| Q2 FY2022 | Jun 30, 2022 | 47M | +2.3% |
| Q1 FY2022 | Mar 31, 2022 | 50M | +8.3% |
| Q4 FY2021 | Dec 31, 2021 | 47M | +4.1% |
| Q3 FY2021 | Sep 30, 2021 | 49M | +10.3% |
| Q2 FY2021 | Jun 30, 2021 | 46M | +4.4% |
| Q1 FY2021 | Mar 31, 2021 | 46M | +4.4% |
| Q4 FY2020 | Dec 31, 2020 | 45M | -18.1% |
| Q3 FY2020 | Sep 30, 2020 | 45M | +21.4% |
| Q2 FY2020 | Jun 30, 2020 | 44M | +21.6% |
| Q1 FY2020 | Mar 31, 2020 | 44M | +20.9% |
| Q4 FY2019 | Dec 31, 2019 | 55M | +52.8% |
| Q3 FY2019 | Sep 30, 2019 | 37M | +3.6% |
| Q2 FY2019 | Jun 30, 2019 | 36M | +4.4% |
| Q1 FY2019 | Mar 31, 2019 | 36M | +4.4% |
| Q4 FY2018 | Dec 31, 2018 | 36M | +4.2% |
| Q3 FY2018 | Sep 30, 2018 | 36M | -5.6% |
| Q2 FY2018 | Jun 30, 2018 | 35M | +1.8% |
| Q1 FY2018 | Mar 31, 2018 | 35M | -8.1% |
| Q4 FY2017 | Dec 31, 2017 | 35M | -6.7% |
| Q3 FY2017 | Sep 30, 2017 | 38M | – |
| Q2 FY2017 | Jun 30, 2017 | 34M | – |
| Q1 FY2017 | Mar 31, 2017 | 38M | – |
| Q4 FY2016 | Dec 31, 2016 | 37M | – |
See a number that looks wrong?